Call Buying Activity Continues in BioCryst Pharma (BCRX), Targeting Upside in Shares Through July -Susquehanna

Susquehanna options strategist Alison Edwards notes call buying activity in BioCryst Pharma (NASDAQ: BCRX), as investors bought ~12k July 9 calls, adding to roughly 20K of the calls bought since early last week. A position of about 30k calls gives investors the right to buy ~3 mln shares if the shares nearly double current levels in mid-July.

You May Also Be Interested In

• Honeywell Aerospace (HONA) dropped from S&P 100
• Zscaler (ZS) call put ratio 2.5 calls to 1 put into quarter results
• Popular stocks with increasing option volume: MU INTC SPCX MSTR SMCI SNDK AVGO PLTR NFLX LULU HOOD